About Netregulus
Netregulus is a company based in Boston (United States) founded in 1999 was acquired by PTC in November 2007. Netregulus has raised $13.4 million across 2 funding rounds from investors including PTC, HSP Group and Advantage Capital. Netregulus operates in a competitive market with competitors including RIMSYS, ValGenesis, Sware, Virtify and 3Aware, among others.
- Headquarter Boston, United States
- SectorsHealthcare
- Website netregulus.com
- Acquired by PTC (Nov 2007)
Funding Insights of Netregulus
Netregulus has successfully raised a total of $13.4M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $6.2 million completed in November 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $13.4M
- Total Rounds 2
- Last Round Series B — $6.2M
- First Round $7.2M
(Mar 2003)
- Investors Count 11
All 2 funding rounds of Netregulus with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2005 | $6.2M | Series B | – | Grayhawk Capital | |
| Mar 2003 | $7.2M | Series B | – | KB Partners, Baird Capital |
12 investors in total: 12 institutional.
Investors in Netregulus
Netregulus has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include PTC, HSP Group and Advantage Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investment firm | – | advantagecap.com | New Orleans, United States | |
- | – | grayhawk.vc | - | |
- | – | wolfventures.com | - | |
Tech & Life Sciences focused VC firm investing in early stage startups in the US | – | kbpartners.com | Highland Park, United States | |
Buyouts are targeted by BPOC, a private equity firm. | – | bpoc.com | Chicago, United States | |
Global private equity and venture capital investments in B2B Tech & Services companies. | – | bairdcapital.com | - | |
Provides customized investment advice and portfolio management for high-net-worth clients. | 1996 | staleycap.com | Pittsburgh, United States | |
- | – | odincapital.com | - | |
A community platform for Pittsburgh Panthers sports news is operated. | – | cardiachill.com | - | |
Offers financial advisory services including planning, analysis, and wealth management. | 2000 | garrettcapital.com | Salt Lake City, United States |
Investor details for Netregulus
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Netregulus
4 dated milestones of Netregulus across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Netregulus is founded.
- Funding First funding round of $7.2M.
- Funding Latest funding round, Series B, of $6.2M.
- Exit Acquired by PTC.
Competitors of Netregulus
Netregulus operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as RIMSYS, ValGenesis, Sware, Virtify and 3Aware, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| rimsys.io | 2017 | Pittsburgh, United States | $25.8M | 31 | Medical device regulatory management software is provided for healthcare organizations. | |
| valgenesis.com | 2005 | Fremont, United States | $24M | 431 | Validation software is provided for life sciences companies. | |
| sware.com | 2015 | Chelsea, United States | $24.37M | – | Validation automation platform for regulated systems is provided. | |
| virtify.com | 2004 | Cambridge, United States | $23.5M | 23 | Delivers content and compliance management software solutions. | |
| 3aware.ai | 2022 | Indianapolis, United States | $2.15M | – | Provider of real-world evidence platform for MedTech device safety and performance | |
| essenvia.com | 2018 | Los Angeles, United States | $5.48M | – | Software for medical device pre- and post-market workflows is provided. | |
| targethealth.com | 1993 | New York, United States | – | 85 | Full-service clinical research organization software and services are provided. | |
| samarindrms.com | 1987 | Deeside, United Kingdom | – | 436 | Software solutions are provided for life sciences and other sectors. |
Detailed competitors of Netregulus
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Netregulus
10 companies that operate in the same segment as Netregulus (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Netregulus
Netregulus was founded in 1999 and raised its 1st funding round 4 years after it was founded.
Netregulus is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Netregulus is a funded company, having raised a total of $13.4M across 2 funding rounds to date. The company's 1st funding round was a Series B of $7.2M, raised on Mar 2003.
NetRegulus was founded in 1999 in Boston, United States. Software solutions are offered by the company for quality and regulatory data management in the medical device, pharmaceutical, and biotechnology sectors. Compliance with FDAs 21 CFR Part 11 is ensured in tools for complaint handling, corrective and preventive action management, clinical study data management, adverse event tracking, nonconformance handling, and related quality, clinical, and regulatory processes.
Netregulus's top competitors include RIMSYS, Sware and ValGenesis.
Netregulus has 12 investors. Key investors include PTC, HSP Group, Advantage Capital, Grayhawk Capital, and Wolf Ventures.
Yes. Netregulus was acquired by PTC in November 2007.